Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite—Resolution for Clinical Development
Jim Zheng(Gilead Sciences (United States)), Jeffrey A. Silverman(University of Arizona), Bill J. Smith(Gilead Sciences (United States)), Raju Subramanian(Gilead Sciences (United States)), J. Andrew Whitney(Hospital for Sick Children), Lisa Moorehead(Gilead Sciences (United States)), Ellen Kwan(Gilead Sciences (United States)), Matthew R. Warr(Gilead Sciences (United States)), Jingyu Zhang(Gilead Sciences (United States)), John Ling(Gilead Sciences (United States)), Bernard P. Murray(Gilead Sciences (United States)), Jeffrey N. Hemenway(Gilead Sciences (United States))
Cited by 56
Related Papers
Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder
|Nature Neuroscience|2017|936
Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
|Drug Metabolism and Disposition|2002|346
Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
|Drug Metabolism and Disposition|2002|325
Comparison of Information-Dependent Acquisition, SWATH, and MS<sup>All</sup> Techniques in Metabolite Identification Study Employing Ultrahigh-Performance Liquid Chromatography–Quadrupole Time-of-Flight Mass Spectrometry
|Analytical Chemistry|2013|211
Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity
|Clinical Pharmacology & Therapeutics|2009|208